SCHEMBL4692979

SCHEMBL4692979

O=C1CN(C(=O)O)Cc2c1cnn2CCSc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.40
NPC1 O15118 10/20 0.40
SMN1; SMN2 Q16637 8/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ALDH1A1 P00352 7/20 0.38
ELANE P08246 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
USP2 O75604 1/20 0.36
MAPT P10636 2/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
KDM4E B2RXH2 2/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4146994 0.85 NPC1 (0.36) RAB9ANPC1SMN1; SMN2CASP3SENP8
SCHEMBL20558012 0.80 ELANE (0.36) ELANEMEN1KMT2A
SCHEMBL4692378 0.77 RAB9A (0.39) RAB9ANPC1SMN1; SMN2CASP3SENP8
SCHEMBL5251685 0.74 CYP1A2 (0.40) RAB9ANPC1SMN1; SMN2CASP3SENP8
SCHEMBL4697047 0.73 ELANE (0.34) SMN1; SMN2ALDH1A1ELANEPOLB
SCHEMBL4693679 0.72 HIF1A (0.43) SMN1; SMN2ELANEMAPTPOLB
SCHEMBL5254840 0.71 RAB9A (0.39) RAB9ANPC1SMN1; SMN2CASP3SENP8
SCHEMBL5258807 0.71 PLK1 (0.50) ELANEKMT2A
SCHEMBL29375980 0.62 KMT2A (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1MEN1
SCHEMBL28695007 0.62 KMT2A (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1798231-A2 Intermediate products for the preparation of antibacterial compounds NOVEXEL (FR) 2007-06-20 EP disclosed